CytomX Therapeutics (CTMX) Stock Chart & Stock Price History $1.02 -0.05 (-4.52%) (As of 12:39 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CytomX Therapeutics Stock Price Performance 5 Day Performance-4.21%1 Month Performance-3.30%3 Month Performance-13.14%6 Month Performance-15.98%Year-To-Date Performance-33.87%1 Year Performance-33.87% Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.Take these 4 steps today to protect your retirement NOW CTMX Stock Chart for Monday, December, 30, 2024 CTMX Chart by TradingView CytomX Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/27/2024$1.13$1.07-5.31%$1.16$1.06926,550 shs$83.74 million12/26/2024$1.07$1.13+5.61%$1.15$1.061.17 million shs$88.43 million12/25/2024$1.07$1.07$1.10$1.061.52 million shs$83.74 million12/24/2024$1.09$1.07-1.83%$1.10$1.061.52 million shs$83.74 million12/23/2024$1.09$1.09$1.11$1.051.33 million shs$85.30 million12/20/2024$1.10$1.09-0.91%$1.10$1.031.08 million shs$85.30 million Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/19/2024$1.06$1.10+3.77%$1.13$1.03683,116 shs$86.09 million12/18/2024$1.13$1.06-6.19%$1.12$1.001.02 million shs$82.96 million12/17/2024$1.15$1.13-1.74%$1.15$1.06820,889 shs$88.43 million12/16/2024$1.11$1.15+3.60%$1.16$1.091.26 million shs$90.00 million12/13/2024$1.12$1.11-0.89%$1.13$1.05697,998 shs$86.87 million12/12/2024$1.18$1.12-5.08%$1.17$1.08699,771 shs$87.65 million12/11/2024$1.21$1.18-2.48%$1.24$1.15592,112 shs$92.35 million12/10/2024$1.26$1.21-3.97%$1.25$1.17959,359 shs$94.70 million12/09/2024$1.18$1.26+6.78%$1.28$1.191.47 million shs$98.61 million12/06/2024$1.16$1.18+1.72%$1.25$1.17925,833 shs$92.35 million12/05/2024$1.29$1.16-10.08%$1.28$1.131.58 million shs$90.78 million12/04/2024$1.23$1.29+4.88%$1.42$1.213.93 million shs$100.95 million12/03/2024$1.09$1.23+12.84%$1.34$1.1812.65 million shs$96.26 million12/02/2024$1.06$1.09+2.83%$1.16$1.031.44 million shs$85.30 million11/29/2024$1.02$1.06+3.92%$1.08$1.01455,842 shs$82.96 million Related Companies Neurogene Stock Chart Eton Pharmaceuticals Stock Chart Aquestive Therapeutics Stock Chart Jasper Therapeutics Stock Chart Valneva Stock Chart biote Stock Chart Acelyrin Stock Chart Voyager Therapeutics Stock Chart Canopy Growth Stock Chart Trevi Therapeutics Stock Chart Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTMX) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
